Gregory B Stock
Harris Center for Precision Wellness at the Icahn School of Medicine at Mount Sinai
Dr. Gregory B Stock – the co-director of the Harris Center for Precision Wellness at the Icahn School of Medicine at Mount Sinai, where he is a research Professor in the Dept. of Genetics and Genomic Sciences – is a leading authority on the broad impacts of genomic and other advanced technologies in the life sciences. Previously, he was the co-founder and CEO both of Signum Biosciences, a Princeton-based biotechnology company developing therapeutics for Alzheimer’s and other neurodegenerative diseases, and of Ecoeos, an innovative genomics company offering genetic tests for susceptibility to environmental toxins. He also was the founding director of UCLA’s program on Medicine, Technology, and Society. Dr. Stock explores our sense of the human using diverse questions about what it would mean to alter fundamental aspects of our biology, build conscious beings out of silicon, and continue our rapid technological advance. A biophysicist by training, he approaches these and other big issues in pragmatic, down-to-earth ways that challenge our thinking and values. He is a major game changer and thought leader who tackles controversial issues.